| Followers | 65 |
| Posts | 23926 |
| Boards Moderated | 0 |
| Alias Born | 11/23/2016 |
Tuesday, January 23, 2024 12:44:05 PM
Late-Stage Pipeline has Achieved Clinical Milestones for Ongoing Development
A company that had truly met all endpoints in Pivotal Trials would not be using that heading for their late stage programme unless they expect to run more trials in those A2-73 indications.
I believe based on the totality of data, safety and unmet need that the chance of approval in Rett and AD are non-zero, but can't reconcile the results of the EXCELLENCE and P2b/3 AD trials with having chances > 50% - sorry!
Notice also the placement of the EXCELLENCE trial on the Stage timeline as apposed to the AVATAR trial.
Now let the emoji disapprovals nonsense crew have their fun.
The longer we wait, the sooner we will get rich!
Recent AVXL News
VAYK Exited Caribbean Investments for $320,000 Profit • VAYK • Jun 27, 2024 9:00 AM
North Bay Resources Announces Successful Flotation Cell Test at Bishop Gold Mill, Inyo County, California • NBRI • Jun 27, 2024 9:00 AM
Branded Legacy, Inc. and Hemp Emu Announce Strategic Partnership to Enhance CBD Product Manufacturing • BLEG • Jun 27, 2024 8:30 AM
POET Wins "Best Optical AI Solution" in 2024 AI Breakthrough Awards Program • POET • Jun 26, 2024 10:09 AM
HealthLynked Promotes Bill Crupi to Chief Operating Officer • HLYK • Jun 26, 2024 8:00 AM
Bantec's Howco Short Term Department of Defense Contract Wins Will Exceed $1,100,000 for the current Quarter • BANT • Jun 25, 2024 10:00 AM
